These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27203621)

  • 1. Characterizing proton-activated materials to develop PET-mediated proton range verification markers.
    Cho J; Ibbott GS; Kerr MD; Amos RA; Stingo FC; Marom EM; Truong MT; Palacio DM; Betancourt SL; Erasmus JJ; DeGroot PM; Carter BW; Gladish GW; Sabloff BS; Benveniste MF; Godoy MC; Patil S; Sorensen J; Mawlawi OR
    Phys Med Biol; 2016 Jun; 61(11):N291-310. PubMed ID: 27203621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of proton-activated implantable markers for proton range verification using PET.
    Cho J; Ibbott G; Gillin M; Gonzalez-Lepera C; Titt U; Paganetti H; Kerr M; Mawlawi O
    Phys Med Biol; 2013 Nov; 58(21):7497-512. PubMed ID: 24099853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of hydrogel fiducial markers for in vivo proton range verification using PET.
    Cho J; Campbell P; Wang M; Alqathami M; Mawlawi O; Kerr M; Cho SH
    Phys Med Biol; 2016 Mar; 61(5):2162-76. PubMed ID: 26907591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/CT imaging for treatment verification after proton therapy: a study with plastic phantoms and metallic implants.
    Parodi K; Paganetti H; Cascio E; Flanz JB; Bonab AA; Alpert NM; Lohmann K; Bortfeld T
    Med Phys; 2007 Feb; 34(2):419-35. PubMed ID: 17388158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of elemental tissue composition following proton treatment using positron emission tomography.
    Cho J; Ibbott G; Gillin M; Gonzalez-Lepera C; Min CH; Zhu X; El Fakhri G; Paganetti H; Mawlawi O
    Phys Med Biol; 2013 Jun; 58(11):3815-35. PubMed ID: 23681070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility study of using fall-off gradients of early and late PET scans for proton range verification.
    Cho J; Grogg K; Min CH; Zhu X; Paganetti H; Lee HC; El Fakhri G
    Med Phys; 2017 May; 44(5):1734-1746. PubMed ID: 28273345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visibility of fiducial markers used for image-guided radiation therapy on optical coherence tomography for registration with CT: An esophageal phantom study.
    Jelvehgaran P; Alderliesten T; Weda JJA; de Bruin M; Faber DJ; Hulshof MCCM; van Leeuwen TG; van Herk M; de Boer JF
    Med Phys; 2017 Dec; 44(12):6570-6582. PubMed ID: 29023771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-beam PET imaging for on-line adaptive proton therapy: an initial phantom study.
    Shao Y; Sun X; Lou K; Zhu XR; Mirkovic D; Poenisch F; Grosshans D
    Phys Med Biol; 2014 Jul; 59(13):3373-88. PubMed ID: 24874943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer.
    De Roover R; Crijns W; Poels K; Peeters R; Draulans C; Haustermans K; Depuydt T
    Med Phys; 2018 May; 45(5):2205-2217. PubMed ID: 29537613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of MRI visibility and artifacts at 3T of liquid fiducial marker in a pancreas tissue-mimicking phantom.
    Schneider S; Jølck RI; Troost EGC; Hoffmann AL
    Med Phys; 2018 Jan; 45(1):37-47. PubMed ID: 29136287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility study of patient-specific dose verification in proton therapy utilizing positron emission tomography (PET) and generative adversarial network (GAN).
    Ma S; Hu Z; Ye K; Zhang X; Wang Y; Peng H
    Med Phys; 2020 Oct; 47(10):5194-5208. PubMed ID: 32772377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring proton radiation therapy with in-room PET imaging.
    Zhu X; España S; Daartz J; Liebsch N; Ouyang J; Paganetti H; Bortfeld TR; El Fakhri G
    Phys Med Biol; 2011 Jul; 56(13):4041-57. PubMed ID: 21677366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of quasi-prompt PET-based range verification in proton therapy.
    Ozoemelam I; van der Graaf E; van Goethem MJ; Kapusta M; Zhang N; Brandenburg S; Dendooven P
    Phys Med Biol; 2020 Dec; 65(24):245013. PubMed ID: 32650323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An experimental approach to improve the Monte Carlo modelling of offline PET/CT-imaging of positron emitters induced by scanned proton beams.
    Bauer J; Unholtz D; Kurz C; Parodi K
    Phys Med Biol; 2013 Aug; 58(15):5193-213. PubMed ID: 23835872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TPS(PET)-A TPS-based approach for in vivo dose verification with PET in proton therapy.
    Frey K; Bauer J; Unholtz D; Kurz C; Krämer M; Bortfeld T; Parodi K
    Phys Med Biol; 2014 Jan; 59(1):1-21. PubMed ID: 24323977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial correlation of proton irradiation-induced activity and dose in polymer gel phantoms for PET/CT delivery verification studies.
    Lopatiuk-Tirpak O; Su Z; Li Z; Hsi W; Meeks S; Zeidan O
    Med Phys; 2011 Dec; 38(12):6483-8. PubMed ID: 22149831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proof-of-concept study of an in-situ partial-ring time-of-flight PET scanner for proton beam verification.
    Krishnamoorthy S; Teo BK; Zou W; McDonough J; Karp JS; Surti S
    IEEE Trans Radiat Plasma Med Sci; 2021 Sep; 5(5):694-702. PubMed ID: 34746539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First full-beam PET acquisitions in proton therapy with a modular dual-head dedicated system.
    Sportelli G; Belcari N; Camarlinghi N; Cirrone GA; Cuttone G; Ferretti S; Kraan A; Ortuño JE; Romano F; Santos A; Straub K; Tramontana A; Guerra AD; Rosso V
    Phys Med Biol; 2014 Jan; 59(1):43-60. PubMed ID: 24321855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of the physical potential of proton beam range verification with PET/CT.
    Knopf A; Parodi K; Paganetti H; Cascio E; Bonab A; Bortfeld T
    Phys Med Biol; 2008 Aug; 53(15):4137-51. PubMed ID: 18635897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the limits of PET/CT imaging at very low true count rates and high random fractions in ion-beam therapy monitoring.
    Kurz C; Bauer J; Conti M; Guérin L; Eriksson L; Parodi K
    Med Phys; 2015 Jul; 42(7):3979-91. PubMed ID: 26133598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.